Form 4: Cencora Officer Sells Shares Under 10b5-1 Plan

Cencora's SVP & Chief Accounting Officer, Lazarus Krikorian, sold 4,031 shares of common stock for $343.235 per share under a pre-planned trading arrangement.

Summary

• Lazarus Krikorian, SVP & Chief Accounting Officer of Cencora, Inc., sold 4,031 shares of common stock.
• The transaction occurred on December 17, 2025, at a price of $343.235 per share.
• The sale was executed pursuant to a Rule 10b5-1(c) pre-planned trading arrangement.
• Following the transaction, Krikorian directly beneficially owns 17,154 shares of Cencora common stock.

Sentiment

Score: 5

Explanation: Neutral. The sale is a routine insider transaction under a 10b5-1 plan, which mitigates any negative sentiment typically associated with insider selling, as it's pre-planned and not indicative of new information.

Positives

• The sale was conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction rather than a discretionary sale based on new, non-public information.

Negatives

• An insider, the SVP & Chief Accounting Officer, sold 4,031 shares of company common stock.

Future Outlook

NA

Industry Context

This is a routine insider transaction disclosure for Cencora, Inc., a major pharmaceutical sourcing and distribution services company. Such sales by executives are common, especially when executed under pre-arranged 10b5-1 plans, and typically do not signal significant shifts in industry trends or competitive landscape.

Related Party Transactions

• Lazarus Krikorian, SVP & Chief Accounting Officer of Cencora, Inc., sold 4,031 shares of company common stock. This is a direct transaction between an insider and the market.

Stakeholder Impact

• Shareholders: The sale by a key executive could be perceived negatively, though the 10b5-1 plan mitigates concerns about informed selling. The total number of shares sold is a small fraction of the company's outstanding shares, so the direct market impact is minimal.

Key Dates

Recommendation

The filing details a routine insider sale by the SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. This type of transaction is typically for personal financial management and does not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this disclosure. Investors should continue to hold and monitor broader company performance and market conditions.

Keywords

Cencora, COR, Insider Trading, Form 4, Stock Sale, Lazarus Krikorian, Chief Accounting Officer, 10b5-1 plan